CASI Pharmaceuticals, Inc.

CASI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$13,468$17,083$47,112$38,704
Short-Term Investments$2,623$13,686$4,225$9,868
Receivables$15,345$10,138$12,973$9,803
Inventory$5,252$15,877$6,138$1,907
Other Curr. Assets$2,888$2,560$2,975$0
Total Curr. Assets$39,576$59,344$73,423$61,970
Property Plant & Equip (Net)$11,360$11,633$13,229$21,819
Goodwill$0$0$0$0
Intangibles$238$1,839$1,063$12,203
Long-Term Investments$1,716$1,681$7,463$40,128
Tax Assets$0$0$0$0
Other NC Assets$587$771$1,056$2,178
Total NC Assets$13,901$15,924$22,811$76,328
Other Assets$197$0$0$0
Total Assets$53,674$75,268$96,234$138,298
Liabilities
Payables$2,723$4,438$3,289$4,789
Short-Term Debt$18,385$0$0$2,166
Tax Payable$0$481$2,050$652
Deferred Revenue$2,474$2,543$2,617$0
Other Curr. Liab.$10,315$0$0-$7,622
Total Curr. Liab.$36,452$16,726$17,005$13,186
LT Debt$0$18,895$0$0
Deferred Rev, NC$0$0$0$2,828
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$12,836$13,866$11,821$13,220
Total NC Liab.$15,371$34,377$12,297$17,153
Other Liabilities$0$0$0$0
Cap. Leases$3,756$2,344$1,344$2,166
Total Liabilities$51,823$51,103$29,302$30,339
Equity
Pref Stock$0$0$0$0
Common Stock$2$1$1$1,399
Retained Earnings-$700,075-$660,817-$637,160-$605,643
AOCI-$1,774-$1,200-$703$1,954
Other Equity$0$0$0-$1,398
Total Equity$1,851$24,165$44,574$84,502
Supplemental Information
Minority Interest$0$0$22,358$23,457
Total Liab. & Tot. Equity$53,674$75,268$96,234$138,298
Net Debt$4,917$1,812-$47,112-$36,538
CASI Pharmaceuticals, Inc. (CASI) Financial Statements & Key Stats | AlphaPilot